文献速递肝病消化道肿瘤与早癌

丙型肝炎病毒抑制miR-181c激活ATM信号并促进肝细胞生长

Hepatitis C Virus Mediated Inhibition of miR-181c Activates ATM Signaling and Promotes Hepatocyte Growth.
PubMed 文献 · Hepatology · 2019-11-03

该研究探讨HCV感染下调miR-181c后通过直接靶向ATM调控细胞周期与凋亡的机制。结果显示HCV感染肝细胞及慢性HCV肝活检中ATM表达升高,miR-181c可直接结合ATM 3'UTR并抑制ATM及其下游Chk2/Akt活化,导致CDK2磷酸化与cyclin-A表达下降、细胞周期阻滞并促进凋亡,且在异种移植小鼠模型中miR-181c显著抑制肿瘤生长。

要点

  • HCV感染肝细胞及慢性HCV肝活检中ATM表达高于对照。
  • miR-181c直接结合ATM 3'UTR并抑制ATM及下游Chk2/Akt活化。
  • miR-181c抑制CDK2磷酸化与cyclin-A表达、阻滞细胞周期并促进凋亡。

核心结论

  • HCV感染抑制肝细胞miR-181c导致ATM激活与凋亡抑制,从而促进细胞周期进展,可能为治疗干预提供潜在靶点。

研究设计与样本

  • 基础机制研究,采用HCV感染肝细胞、慢性HCV感染肝活检标本及异种移植人肝细胞癌小鼠模型。

主要发现

  • HCV感染肝细胞与慢性HCV感染肝活检标本中ATM表达高于对照。
  • miR-181c与ATM 3'UTR直接互作,且ATM存在于miR-181c相关RNA诱导沉默复合物中。
  • 外源性miR-181c抑制ATM表达及其下游Chk2与Akt活化;anti-miR-181c可恢复ATM与磷酸化Akt。
  • miR-181c显著抑制磷酸化CDK2与cyclin-A表达、阻滞细胞周期,并促进HCV感染肝细胞凋亡,该凋亡可被缺失miR-181c结合位点的ATM克隆过表达所抑制。
  • miR-181c在异种移植人肝细胞癌小鼠模型中显著抑制肿瘤生长。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Hepatitis C virus (HCV) infection promotes hepatocyte growth and progress to hepatocellular carcinoma. We previously observed that HCV infection of hepatocytes transcriptionally down-regulates miR-181c expression through CCAAT/enhancer binding protein β (C/EBP-β). Here, we examined the role of miR-181c in the regulation of cell cycle progression in relation to HCV infection. In silico analysis suggested that ataxia-telangiectasia mutated (ATM) protein, a protein kinase, is a direct target of miR-181c. ATM is a central mediator of response for cellular DNA double-strand break. APPROACH AND RESULTS: Our results demonstrated that ATM expression is higher in HCV-infected hepatocytes and chronic HCV-infected liver biopsy specimens. We have shown a direct interaction of miR-181c with the 3' untranslated region of ATM, and the presence of ATM in miR-181c-associated RNA-induced silencing complex. Exogenous expression of miR-181c inhibited ATM expression and activation of its downstream molecules, Chk2 and Akt. On the other hand, introduction of anti-miR-181c restored ATM and phosphorylated Akt. Furthermore, introduction of miR-181c significantly inhibited phospho-cyclin-dependent kinase 2 (CDK2) and cyclin-A expression, arresting cell cycle progression, whereas overexpression of miR-181c promoted apoptosis of HCV-infected hepatocytes and can be inhibited by overexpression of ATM from a clone lacking miR-181c binding sites. In addition, miR-181c significantly regressed tumor growth in the xenograft human hepatocellular carcinoma mouse model. CONCLUSIONS: Together, our results suggest that HCV infection suppresses miR-181c in hepatocytes, resulting in ATM activation and apoptosis inhibition for promotion of cell cycle progression. The results provide mechanistic insight into understanding the role of miR-181c in HCV-associated hepatocyte growth promotion, and may have the potential for therapeutic intervention.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Patra T, Meyer K, Ray RB, et al. Hepatitis C Virus Mediated Inhibition of miR-181c Activates ATM Signaling and Promotes Hepatocyte Growth. Hepatology. 2019. PMID: 31400158. doi:10.1002/hep.30893

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。